Dose optimization for the treatment of anaplastic thyroid carcinoma: A comparison of treatment planning techniques

Citation
Md. Posner et al., Dose optimization for the treatment of anaplastic thyroid carcinoma: A comparison of treatment planning techniques, INT J RAD O, 48(2), 2000, pp. 475-483
Citations number
30
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
ISSN journal
03603016 → ACNP
Volume
48
Issue
2
Year of publication
2000
Pages
475 - 483
Database
ISI
SICI code
0360-3016(20000901)48:2<475:DOFTTO>2.0.ZU;2-U
Abstract
Purpose: To evaluate and compare dose optimization for the treatment of ana plastic thyroid carcinoma using a 3D conformal plan, and two 3D intensity-m odulated inverse plans. Methods and Materials: After patient immobilization using an alpha cradle a nd head-mask system, a postoperative CT scan was obtained to delineate the gross tumor volume (GTV), the clinical tumor volume (CTV), and adjacent cri tical structures. Treatment plans were generated using UM-Plan (University of Michigan), Peacock-Plan and Corvus (NOMOS Corporation, Sewickley, PA). I sodoses were displayed in the sagittal, coronal, and multiple axial planes, and dose-volume histograms (DVH) were generated for the GTV, CTV, and crit ical normal tissues. Treatment times were estimated to compare the practica lity of delivering each plan in a busy radiotherapy department. Results: All three treatment planning systems were able to deliver a minimu m dose of 60 Gy to the GTV while keeping the maximum spinal cord dose at or below 45 Gy, However, there were differences in the doses delivered to 50% and 5% of the cord, the minimum CTV dose, and the overall treatment time. The PeacockPlan best spared the uninvolved tissues of the posterior neck, a nd provided the lowest dose to the cord without compromising the CTV. Conclusions: Inverse treatment planning provides superior dose optimization for the treatment of anaplastic thyroid carcinoma. The radiobiologic impac t of intensity modulation for this tumor should be further tested clinicall y. (C) 2000 Elsevier Science Inc.